HOOK Insider Trading Activity and SEC Form 4 Filings
HOOK insider trading summary
No open-market insider purchases or sales of HOOKIPA Pharma Inc. (HOOK) have been reported on SEC Form 4 in the past 12 months.
Latest HOOK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 19, 2025 | Malte Peters | Chief Executive Officer | Sell | $21K (25,172 @ $0.82) |
| Jul 22, 2025 | Malte Peters | Chief Executive Officer | Sell | $27K (29,176 @ $0.92) |
| Jul 22, 2025 | Mary Theresa Coelho | EVP and CFO | Sell | $13K (13,609 @ $0.92) |
| Aug 21, 2023 | Reinhard Kandera | Chief Financial Officer | Buy | $5K (7,000 @ $0.72) |
| Aug 16, 2023 | Reinhard Kandera | Chief Financial Officer | Buy | $6K (8,000 @ $0.71) |
| Jul 11, 2023 | Jorn Aldag | Chief Executive Officer | Buy | $4K (5,000 @ $0.83) |
| Jul 7, 2023 | Jorn Aldag | Chief Executive Officer | Buy | $4K (5,000 @ $0.81) |
| Jul 5, 2023 | Jorn Aldag | Chief Executive Officer | Buy | $4K (5,000 @ $0.89) |
| Jul 3, 2023 | Jorn Aldag | Chief Executive Officer | Buy | $4K (5,000 @ $0.89) |
| Jun 30, 2023 | Reinhard Kandera | Chief Financial Officer | Buy | $11K (12,000 @ $0.88) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.